Market Tracker

09/18 6:05pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

During the Trading Day
30.42 +0.73 / +2.46%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
30.42 0.00 / 0.00%
 
Volume: 14.1K

Today’s Trading

Previous close29.69
Today’s open29.92
Day’s range29.54 - 30.66
Volume486,798
Average volume (3 months)453,290
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 09/18/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)-33.21%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio67.6
Price/Sales3.49
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+0.40+2.50%
KPTIKaryopharm Therapeut...+0.08+0.20%
INSYInsys Therapeutics I...+0.11+0.32%
ACHNAchillion Pharmaceut...0.000.00%
Data as of 3:59pm ET, 09/18/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.06
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts